Travere Therapeutics (TVTX) Q4 2022 Earnings

23FebConfirmed
May 22
Aug 22
Oct 22
Q4 2022
-1.2
-1.05
-0.91
-0.76

Details

Expected EPS
-1.07
Actual EPS
-0.76
Surprise EPS
0.31
Surprise Percent
+28.97%

Description

Travere Therapeutics (TVTX) has reported earnings of -0.76 per share for Q4 2022.

0 Comments

Share your thoughts